# Allstate Corp: financial statements, quarterly

ALL · NYSE · CIK 899051 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/all.md) · [Financials](/companies/all/financials.md) · [Filings](/companies/all/filings.md) · [Insiders](/companies/all/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/all/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [14.5](/filings/0000899051-25-000015.md) | [14.8](/filings/0000899051-25-000015.md) | [15.3](/filings/0000899051-26-000031.md) | [15.7](/filings/0000899051-26-000031.md) | [16.6](/filings/0000899051-26-000031.md) | [16.5](/filings/0000899051-26-000031.md) | [16.5](/filings/0000899051-26-000075.md) | [16.6](/filings/0000899051-26-000118.md) | [17.3](/filings/0000899051-26-000031.md) | [17.3](/filings/0000899051-26-000031.md) | [16.9](/filings/0000899051-26-000075.md) | [18.6](/filings/0000899051-26-000118.md) |
| Interest expense | $bn | [0.1](/filings/0000899051-23-000076.md) | [0.1 d](/filings/0000899051-24-000013.md) | [0.1](/filings/0000899051-24-000024.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $bn | [(0.0)](/filings/0000899051-24-000083.md) | [0.3 d](/filings/0000899051-26-000031.md) | [0.3](/filings/0000899051-25-000042.md) | [0.1](/filings/0000899051-25-000070.md) | [0.3](/filings/0000899051-25-000102.md) | [0.6 d](/filings/0000899051-26-000031.md) | [0.1](/filings/0000899051-26-000075.md) | [0.6](/filings/0000899051-26-000118.md) | [1.1](/filings/0000899051-25-000102.md) | [1.1 d](/filings/0000899051-26-000031.md) | [0.7](/filings/0000899051-26-000075.md) | [0.9](/filings/0000899051-26-000118.md) |
| Net income | $bn | [(0.0)](/filings/0000899051-24-000083.md) | [1.5](/filings/0000899051-25-000015.md) | [1.2](/filings/0000899051-25-000042.md) | [0.3](/filings/0000899051-25-000070.md) | [1.2](/filings/0000899051-25-000102.md) | [1.9](/filings/0000899051-26-000031.md) | [0.6](/filings/0000899051-26-000075.md) | [2.1](/filings/0000899051-26-000118.md) | [3.7](/filings/0000899051-25-000102.md) | [3.8](/filings/0000899051-26-000031.md) | [2.5](/filings/0000899051-26-000075.md) | [3.3](/filings/0000899051-26-000118.md) |
| Diluted EPS | $ per share | [(0.16)](/filings/0000899051-25-000015.md) | [5.52](/filings/0000899051-25-000015.md) | [4.46](/filings/0000899051-26-000031.md) | [1.13](/filings/0000899051-26-000031.md) | [4.33](/filings/0000899051-26-000031.md) | [7.07](/filings/0000899051-26-000031.md) | [2.11](/filings/0000899051-26-000075.md) | [7.76](/filings/0000899051-26-000118.md) | [13.95](/filings/0000899051-26-000031.md) | [14.37](/filings/0000899051-26-000031.md) | [9.25](/filings/0000899051-26-000075.md) | [12.51](/filings/0000899051-26-000118.md) |
| Basic EPS | $ per share | [(0.16)](/filings/0000899051-25-000015.md) | [5.57](/filings/0000899051-25-000015.md) | [4.51](/filings/0000899051-26-000031.md) | [1.14](/filings/0000899051-26-000031.md) | [4.39](/filings/0000899051-26-000031.md) | [7.16](/filings/0000899051-26-000031.md) | [2.13](/filings/0000899051-26-000075.md) | [7.86](/filings/0000899051-26-000118.md) | [14.13](/filings/0000899051-26-000031.md) | [14.55](/filings/0000899051-26-000031.md) | [9.36](/filings/0000899051-26-000075.md) | [12.66](/filings/0000899051-26-000118.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.9](/filings/0000899051-23-000076.md) | [0.7](/filings/0000899051-25-000015.md) | [0.9](/filings/0000899051-24-000024.md) | [0.6](/filings/0000899051-24-000054.md) | [0.8](/filings/0000899051-24-000083.md) | [0.7](/filings/0000899051-26-000031.md) | [0.8](/filings/0000899051-25-000042.md) | [1.0](/filings/0000899051-25-000070.md) | [0.9](/filings/0000899051-25-000102.md) | [0.7](/filings/0000899051-26-000118.md) | [0.7](/filings/0000899051-26-000075.md) | [0.8](/filings/0000899051-26-000118.md) |
| Total assets | $bn | [101](/filings/0000899051-23-000076.md) | [103](/filings/0000899051-25-000015.md) | [105](/filings/0000899051-24-000024.md) | [108](/filings/0000899051-24-000054.md) | [114](/filings/0000899051-24-000083.md) | [112](/filings/0000899051-26-000031.md) | [115](/filings/0000899051-25-000042.md) | [116](/filings/0000899051-25-000070.md) | [120](/filings/0000899051-25-000102.md) | [120](/filings/0000899051-26-000118.md) | [124](/filings/0000899051-26-000075.md) | [125](/filings/0000899051-26-000118.md) |
| Total liabilities | $bn | [86.7](/filings/0000899051-23-000076.md) | [85.7](/filings/0000899051-25-000015.md) | [86.8](/filings/0000899051-24-000024.md) | [89.8](/filings/0000899051-24-000054.md) | [92.9](/filings/0000899051-24-000083.md) | [90.3](/filings/0000899051-26-000031.md) | [93.1](/filings/0000899051-25-000042.md) | [91.9](/filings/0000899051-25-000070.md) | [92.9](/filings/0000899051-25-000102.md) | [89.2](/filings/0000899051-26-000118.md) | [92.4](/filings/0000899051-26-000075.md) | [91.1](/filings/0000899051-26-000118.md) |
| Long-term debt | $bn | [7.9](/filings/0000899051-23-000076.md) | [7.9](/filings/0000899051-25-000015.md) | [7.9](/filings/0000899051-24-000024.md) | [8.1](/filings/0000899051-24-000054.md) | [8.1](/filings/0000899051-24-000083.md) | [8.1](/filings/0000899051-26-000031.md) | [8.1](/filings/0000899051-25-000042.md) | [8.1](/filings/0000899051-25-000070.md) | [8.1](/filings/0000899051-25-000102.md) | [7.5](/filings/0000899051-26-000118.md) | [7.5](/filings/0000899051-26-000075.md) | [7.5](/filings/0000899051-26-000118.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [14.6](/filings/0000899051-24-000083.md) | [17.8](/filings/0000899051-26-000031.md) | [18.6](/filings/0000899051-25-000042.md) | [18.6](/filings/0000899051-25-000070.md) | [20.9](/filings/0000899051-25-000102.md) | [21.4](/filings/0000899051-26-000031.md) | [22.1](/filings/0000899051-26-000075.md) | [24.0](/filings/0000899051-26-000118.md) | [27.5](/filings/0000899051-25-000102.md) | [30.6](/filings/0000899051-26-000118.md) | [31.6](/filings/0000899051-26-000075.md) | [33.7](/filings/0000899051-26-000118.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,233 d](/filings/0000899051-24-000083.md) | [1,225 d](/filings/0000899051-26-000031.md) | [1,666](/filings/0000899051-25-000042.md) | [2,359 d](/filings/0000899051-25-000070.md) | [3,201 d](/filings/0000899051-25-000102.md) | [1,705 d](/filings/0000899051-26-000031.md) | [1,964](/filings/0000899051-26-000075.md) | [1,873 d](/filings/0000899051-26-000118.md) | [3,284 d](/filings/0000899051-25-000102.md) | [2,989 d](/filings/0000899051-26-000031.md) | [3,562](/filings/0000899051-26-000075.md) | [2,634 d](/filings/0000899051-26-000118.md) |
| Capital expenditure | $m | [55.0 d](/filings/0000899051-24-000083.md) | [71.0 d](/filings/0000899051-26-000031.md) | [41.0](/filings/0000899051-25-000042.md) | [56.0 d](/filings/0000899051-25-000070.md) | [63.0 d](/filings/0000899051-25-000102.md) | [50.0 d](/filings/0000899051-26-000031.md) | [92.0](/filings/0000899051-26-000075.md) | [(1.0) d](/filings/0000899051-26-000118.md) | [48.0 d](/filings/0000899051-25-000102.md) | [89.0 d](/filings/0000899051-26-000031.md) | [40.0](/filings/0000899051-26-000075.md) | [43.0 d](/filings/0000899051-26-000118.md) |
| Dividends paid | $m | [233 d](/filings/0000899051-24-000083.md) | [233 d](/filings/0000899051-26-000031.md) | [233](/filings/0000899051-25-000042.md) | [243 d](/filings/0000899051-25-000070.md) | [243 d](/filings/0000899051-25-000102.md) | [243 d](/filings/0000899051-26-000031.md) | [244](/filings/0000899051-26-000075.md) | [265 d](/filings/0000899051-26-000118.md) | [264 d](/filings/0000899051-25-000102.md) | [263 d](/filings/0000899051-26-000031.md) | [261](/filings/0000899051-26-000075.md) | [280 d](/filings/0000899051-26-000118.md) |
| Share repurchases | $m | [28.0 d](/filings/0000899051-24-000083.md) | [0.0 d](/filings/0000899051-26-000031.md) | [0.0](/filings/0000899051-25-000042.md) | [0.0 d](/filings/0000899051-25-000070.md) | [0.0 d](/filings/0000899051-25-000102.md) | [2.0 d](/filings/0000899051-26-000031.md) | [99.0](/filings/0000899051-26-000075.md) | [340 d](/filings/0000899051-26-000118.md) | [360 d](/filings/0000899051-25-000102.md) | [434 d](/filings/0000899051-26-000031.md) | [614](/filings/0000899051-26-000075.md) | [1,051 d](/filings/0000899051-26-000118.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [269](/filings/0000899051-23-000076.md) | [264](/filings/0000899051-24-000024.md) | [263](/filings/0000899051-24-000054.md) | [262](/filings/0000899051-24-000083.md) | [267](/filings/0000899051-25-000042.md) | [267](/filings/0000899051-25-000070.md) | [268](/filings/0000899051-25-000102.md) | [269](/filings/0000899051-26-000075.md) | [268](/filings/0000899051-26-000118.md) | [266](/filings/0000899051-25-000102.md) | [263](/filings/0000899051-26-000075.md) | [259](/filings/0000899051-26-000118.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 252,857,950 at 2026-07-16, from the cover of the [10-Q filed 2026-08-05](/filings/0000899051-26-000118.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.